Japan’s FUJIFILM is making some big bets in a small country with a $928 million capital injection into its FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization (CDMO) for biologics and advanced therapies. Doubling the Danish...
Contract Manufacturing
Category
Explosive Gene Therapy Pipeline Growth Leads to Demand for New Biologic Contract Manufacturing Services
Gene therapies represent a big future. Already, the gene therapy pipeline has been growing exponentially. The FDA will receive more than 200 investigative new drug applications for cell and gene therapies by 2020. By 2025, it is predicted that 10 to 20 cell and gene...